Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
25
ALGM Quote, Financials, Valuation and Earnings
Last price:
$26.58
Seasonality move
:
-9.3%
Day range:
$26.11 - $27.22
52-week range:
$18.59 - $33.26
Dividend yield:
0%
P/E ratio:
64.55x
P/S ratio:
6.54x
P/B ratio:
5.24x
Volume:
3.3M
Avg. volume:
3.7M
1-year change:
-4.22%
Market cap:
$4.9B
Revenue:
$1B
EPS (TTM):
-$0.35
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $650.1M | $591.2M | $768.7M | $973.7M | $1B | |
| Revenue Growth (YoY) | -10.25% | -9.06% | 30.02% | 26.67% | 7.78% | |
| Cost of Revenues | $388.8M | $312.3M | $361.2M | $427.6M | $474.8M | |
| Gross Profit | $261.3M | $278.9M | $407.5M | $546.1M | $574.5M | |
| Gross Profit Margin | 40.19% | 47.18% | 53.01% | 56.09% | 54.75% | |
| R&D Expenses | $102.1M | $108.6M | $121.9M | $150.9M | $176.6M | |
| Selling, General & Admin | $106.4M | $153.5M | $148.9M | $191.9M | $188.4M | |
| Other Inc / (Exp) | $560K | -$15.6M | $5.2M | $8.7M | -$7M | |
| Operating Expenses | $208.4M | $262.1M | $270.8M | $342.8M | $365.1M | |
| Operating Income | $52.8M | $16.8M | $136.7M | $203.3M | $209.5M | |
| Net Interest Expenses | $110K | $2.6M | $1.1M | $612K | $7.6M | |
| EBT. Incl. Unusual Items | $53.3M | -$1.5M | $140.7M | $211.3M | $194.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $16.2M | -$19.6M | $21.2M | $23.9M | $41.9M | |
| Net Income to Company | $37.1M | $18.1M | $119.6M | $187.5M | $152.9M | |
| Minority Interest in Earnings | -$134K | -$148K | -$148K | -$137K | -$191K | |
| Net Income to Common Excl Extra Items | $37M | $18M | $119.4M | $187.4M | $152.7M | |
| Basic EPS (Cont. Ops) | $0.20 | $0.22 | $0.63 | $0.98 | $0.79 | |
| Diluted EPS (Cont. Ops) | $0.20 | $0.10 | $0.62 | $0.97 | $0.78 | |
| Weighted Average Basic Share | $187.7M | $83.4M | $189.7M | $191.2M | $192.6M | |
| Weighted Average Diluted Share | $187.7M | $176.4M | $191.8M | $193.7M | $194.7M | |
| EBITDA | $117.4M | $50.7M | $191.8M | $264.5M | $276.9M | |
| EBIT | $53.4M | $2.4M | $143.2M | $213.7M | $205.6M | |
| Revenue (Reported) | $650.1M | $591.2M | $768.7M | $973.7M | $1B | |
| Operating Income (Reported) | $52.8M | $16.8M | $136.7M | $203.3M | $209.5M | |
| Operating Income (Adjusted) | $53.4M | $2.4M | $143.2M | $213.7M | $205.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $164.4M | $186.6M | $248.8M | $255M | $177.9M | |
| Revenue Growth (YoY) | 2.91% | 13.49% | 33.31% | 2.49% | -30.24% | |
| Cost of Revenues | $90M | $85.5M | $106.2M | $121.2M | $96.7M | |
| Gross Profit | $74.4M | $101.2M | $142.6M | $133.8M | $81.2M | |
| Gross Profit Margin | 45.26% | 54.21% | 57.32% | 52.49% | 45.66% | |
| R&D Expenses | $31M | $30.3M | $39.6M | $44.4M | $43.3M | |
| Selling, General & Admin | $67.7M | $38M | $37.4M | $52.7M | $37.9M | |
| Other Inc / (Exp) | -$8.8M | $6.6M | $6.7M | $2.7M | -$187K | |
| Operating Expenses | $98.6M | $68.3M | $77M | $97.1M | $81.3M | |
| Operating Income | -$24.2M | $32.9M | $65.6M | $36.7M | -$41K | |
| Net Interest Expenses | $2.6M | $269K | $253K | $3M | $7.4M | |
| EBT. Incl. Unusual Items | -$35.6M | $39.3M | $72.1M | $36.4M | -$7.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$30.5M | $6.3M | $7.5M | $3M | -$803K | |
| Net Income to Company | -$5.1M | $33M | $64.6M | $33.4M | -$6.8M | |
| Minority Interest in Earnings | -$35K | -$37K | -$32K | -$57K | -$61K | |
| Net Income to Common Excl Extra Items | -$5.1M | $32.9M | $64.5M | $33.3M | -$6.9M | |
| Basic EPS (Cont. Ops) | -$0.04 | $0.17 | $0.34 | $0.17 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -$0.04 | $0.17 | $0.33 | $0.17 | -$0.04 | |
| Weighted Average Basic Share | $124.4M | $189.7M | $191.3M | $192.7M | $184M | |
| Weighted Average Diluted Share | $124.4M | $192.1M | $193.9M | $194.6M | $184M | |
| EBITDA | -$20.8M | $51.7M | $85.3M | $60.4M | $16.3M | |
| EBIT | -$33M | $39.7M | $72.7M | $40.2M | $160K | |
| Revenue (Reported) | $164.4M | $186.6M | $248.8M | $255M | $177.9M | |
| Operating Income (Reported) | -$24.2M | $32.9M | $65.6M | $36.7M | -$41K | |
| Operating Income (Adjusted) | -$33M | $39.7M | $72.7M | $40.2M | $160K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $590.7M | $743.5M | $904.5M | $1.1B | $772.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $327M | $358.6M | $401.9M | $473.9M | $407.9M | |
| Gross Profit | $263.7M | $384.9M | $502.6M | $604.4M | $364.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $105M | $117.6M | $141.4M | $172.6M | $177.9M | |
| Selling, General & Admin | $147M | $138.9M | $188.6M | $188.3M | $164.5M | |
| Other Inc / (Exp) | -$10.3M | $1.7M | $759K | $5M | -$45.5M | |
| Operating Expenses | $252M | $256.5M | $330M | $360.9M | $342.4M | |
| Operating Income | $11.6M | $128.4M | $172.6M | $243.5M | $22.5M | |
| Net Interest Expenses | $2M | $2.4M | -- | $3M | $27M | |
| EBT. Incl. Unusual Items | -$709K | $127.6M | $173.6M | $245.5M | -$50M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$23.5M | $25M | $22.4M | $23.5M | $15.1M | |
| Net Income to Company | $22.7M | $102.6M | $151.1M | $222M | -$65.1M | |
| Minority Interest in Earnings | -$136K | -$157K | -$138K | -$185K | -$226K | |
| Net Income to Common Excl Extra Items | $22.6M | $102.4M | $151M | $221.8M | -$65.3M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.54 | $0.78 | $1.15 | -$0.35 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.53 | $0.77 | $1.14 | -$0.35 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $56.1M | $180.1M | $224.1M | $315.3M | $49.3M | |
| EBIT | $3.4M | $131.5M | $175.4M | $251.6M | -$21.1M | |
| Revenue (Reported) | $590.7M | $743.5M | $904.5M | $1.1B | $772.8M | |
| Operating Income (Reported) | $11.6M | $128.4M | $172.6M | $243.5M | $22.5M | |
| Operating Income (Adjusted) | $3.4M | $131.5M | $175.4M | $251.6M | -$21.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $416.1M | $568.4M | $704.2M | $808.8M | $532.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $224.2M | $270.5M | $311.2M | $357.5M | $290.5M | |
| Gross Profit | $191.9M | $297.9M | $393M | $451.3M | $241.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $80.5M | $89.4M | $109M | $130.8M | $132M | |
| Selling, General & Admin | $118.7M | $104.1M | $143.8M | $140.1M | $116.2M | |
| Other Inc / (Exp) | -$9.3M | $8.1M | $3.7M | $30K | -$38.5M | |
| Operating Expenses | $199.2M | $193.6M | $252.8M | $270.9M | $248.3M | |
| Operating Income | -$7.3M | $104.3M | $140.2M | $180.3M | -$6.6M | |
| Net Interest Expenses | $2.6M | $1.8M | $437K | $3M | $22.2M | |
| EBT. Incl. Unusual Items | -$18.5M | $110.6M | $143.4M | $177.5M | -$67.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$27.9M | $16.7M | $17.9M | $17.6M | -$9.2M | |
| Net Income to Company | $9.4M | $93.9M | $125.5M | $160M | -$58M | |
| Minority Interest in Earnings | -$103K | -$112K | -$102K | -$150K | -$185K | |
| Net Income to Common Excl Extra Items | $9.3M | $93.8M | $125.4M | $159.8M | -$58.2M | |
| Basic EPS (Cont. Ops) | $0.04 | $0.49 | $0.65 | $0.83 | -$0.31 | |
| Diluted EPS (Cont. Ops) | $0.04 | $0.48 | $0.64 | $0.82 | -$0.31 | |
| Weighted Average Basic Share | $501.6M | $569M | $573.3M | $577.2M | $566.7M | |
| Weighted Average Diluted Share | $501.6M | $574.9M | $579M | $584.7M | $566.7M | |
| EBITDA | $20.2M | $149.1M | $181.6M | $232.5M | $4.8M | |
| EBIT | -$16.1M | $112.6M | $144.8M | $182.9M | -$43.8M | |
| Revenue (Reported) | $416.1M | $568.4M | $704.2M | $808.8M | $532.2M | |
| Operating Income (Reported) | -$7.3M | $104.3M | $140.2M | $180.3M | -$6.6M | |
| Operating Income (Adjusted) | -$16.1M | $112.6M | $144.8M | $182.9M | -$43.8M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $214.5M | $197.2M | $282.4M | $351.6M | $212.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $90.3M | $93.3M | $114.7M | $124.8M | $118.7M | |
| Inventory | $127.2M | $87.5M | $86.2M | $151.3M | $162.3M | |
| Prepaid Expenses | -- | -- | -- | $2.1M | $31.9M | |
| Other Current Assets | $9M | $18.4M | $15M | $23.3M | $30.7M | |
| Total Current Assets | $448.2M | $430.6M | $511.7M | $665.8M | $572.2M | |
| Property Plant And Equipment | $332.3M | $192.4M | $226.1M | $280M | $341.5M | |
| Long-Term Investments | -- | $26.7M | $40M | $47.2M | $26.7M | |
| Goodwill | $1.3M | $20.1M | $20M | $27.7M | $202.4M | |
| Other Intangibles | $20M | $36.4M | $36M | $52.4M | $276.9M | |
| Other Long-Term Assets | $8.8M | $1.4M | $1.4M | $4.8M | $3.4M | |
| Total Assets | $817.8M | $747.7M | $892.6M | $1.2B | $1.5B | |
| Accounts Payable | $20.8M | $35.4M | $29.8M | $56.3M | $36M | |
| Accrued Expenses | $35M | $68.4M | $50.1M | $71.3M | $55.8M | |
| Current Portion Of Long-Term Debt | $68M | -- | -- | -- | $3.9M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $3.7M | $4.5M | $5.3M | |
| Other Current Liabilities | $5.3M | $3.7M | $7.8M | $9.6M | $6.4M | |
| Total Current Liabilities | $150.1M | $116.7M | $104.2M | $165.3M | $117.9M | |
| Long-Term Debt | $17.7M | $25M | $25M | $25M | $249.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $183.7M | $160.8M | $157.3M | $214.3M | $398.9M | |
| Common Stock | $106K | $1.9M | $1.9M | $1.9M | $1.9M | |
| Other Common Equity Adj | -$20M | -$11.9M | -$18.4M | -$20.8M | -$28.8M | |
| Common Equity | $633.2M | $585.8M | $734.2M | $965.6M | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $950K | $1.1M | $1.2M | $1.2M | $1.3M | |
| Total Equity | $634.1M | $586.9M | $735.4M | $966.8M | $1.1B | |
| Total Liabilities and Equity | $817.8M | $747.7M | $892.6M | $1.2B | $1.5B | |
| Cash and Short Terms | $214.5M | $197.2M | $282.4M | $351.6M | $212.1M | |
| Total Debt | $85.7M | $25M | $25M | $25M | $253.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $157.7M | $259.2M | $334.3M | $214.3M | $138.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $87.5M | $104.5M | $128.3M | $114.5M | $83.8M | |
| Inventory | $94M | $78.9M | $119.6M | $165.6M | $193.1M | |
| Prepaid Expenses | -- | -- | -- | -- | $36M | |
| Other Current Assets | $31.5M | $16.2M | $22M | $42M | $33.7M | |
| Total Current Assets | $378.5M | $469.2M | $620M | $549.5M | $495.6M | |
| Property Plant And Equipment | $214.4M | $223.6M | $246.8M | $347.4M | $342.1M | |
| Long-Term Investments | $26.7M | $40.8M | $28M | $26M | $30.9M | |
| Goodwill | $20.2M | $20M | $28.2M | $214.7M | $202.1M | |
| Other Intangibles | $36.4M | $36M | $53.1M | $293.7M | $261.6M | |
| Other Long-Term Assets | $1.9M | $1.3M | $52.3M | $48.9M | $44.1M | |
| Total Assets | $711.9M | $851.4M | $1.1B | $1.6B | $1.4B | |
| Accounts Payable | $20.3M | $34.2M | $49.9M | $37.6M | $39.7M | |
| Accrued Expenses | $34.5M | $46.1M | $57.1M | $70M | $52.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $4M | $1.4M | |
| Current Portion Of Capital Lease Obligations | -- | $3.3M | $3.8M | $5.5M | $5.4M | |
| Other Current Liabilities | $22.3M | $4.9M | $8.9M | -- | -- | |
| Total Current Liabilities | $89.1M | $100.8M | $137.2M | $120.2M | $100.9M | |
| Long-Term Debt | $25M | $25M | $25M | $250.5M | $374.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $135M | $155.6M | $189.5M | $429.8M | $507.3M | |
| Common Stock | $1.9M | $1.9M | $1.9M | $1.9M | $1.8M | |
| Other Common Equity Adj | -$10.2M | -$16.7M | -$24.8M | -$21.9M | -$34.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.1M | $1.2M | $1.2M | $1.3M | $1.4M | |
| Total Equity | $576.9M | $695.8M | $894.6M | $1.1B | $934.4M | |
| Total Liabilities and Equity | $711.9M | $851.4M | $1.1B | $1.6B | $1.4B | |
| Cash and Short Terms | $157.7M | $259.2M | $334.3M | $214.3M | $138.5M | |
| Total Debt | $25M | $25M | $25M | $254.4M | $376.1M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $37.1M | $18.1M | $119.6M | $187.5M | $152.9M | |
| Depreciation & Amoritzation | $64M | $48.3M | $48.5M | $50.8M | $71.4M | |
| Stock-Based Compensation | $1.4M | $49.9M | $33.5M | $61.8M | $42.5M | |
| Change in Accounts Receivable | $16.8M | -$9.3M | -$21M | -$10.3M | -$9M | |
| Change in Inventories | $346K | $7.6M | -$4.5M | -$75.2M | -$15.8M | |
| Cash From Operations | $81.4M | $120.6M | $156.1M | $193.2M | $181.7M | |
| Capital Expenditures | $45.6M | $40.7M | $69.9M | $79.8M | $124.8M | |
| Cash Acquisitions | -- | -$27.9M | -$14.5M | -$19.9M | -$408.1M | |
| Cash From Investing | -$41.7M | -$68.2M | -$66.3M | -$99.7M | -$516.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -$400M | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $43M | $315.7M | -- | -- | $245.5M | |
| Long-Term Debt Repaid | -- | -$333M | -$7.5M | -$7.5M | -$26.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $39.5M | $51.4M | -$638K | -$15.3M | -$23.6M | |
| Cash From Financing | $82.5M | -$72.2M | -$5.3M | -$20M | $198.9M | |
| Beginning Cash (CF) | $103.3M | $219.9M | $203.9M | $289.8M | $358.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $122.2M | -$19.9M | $84.6M | $73.5M | -$136.1M | |
| Ending Cash (CF) | $219.9M | $203.9M | $289.8M | $358.7M | $222.2M | |
| Levered Free Cash Flow | $35.8M | $79.9M | $86.2M | $113.4M | $56.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.1M | $33M | $64.6M | $33.4M | -$6.8M | |
| Depreciation & Amoritzation | $12.2M | $12M | $12.6M | $20.2M | $16.1M | |
| Stock-Based Compensation | $45.9M | $7.6M | $8.9M | $10.9M | $10.6M | |
| Change in Accounts Receivable | -$10.8M | -$4M | -$12M | $5.1M | -$7.1M | |
| Change in Inventories | $9.9M | -$1.2M | -$21.8M | $11.3M | -$19.2M | |
| Cash From Operations | $34.9M | $48.7M | $53.9M | $72.6M | -$8.2M | |
| Capital Expenditures | $7.8M | $22M | $14.3M | $34.4M | $13.6M | |
| Cash Acquisitions | -- | -- | -- | -$408.1M | -- | |
| Cash From Investing | -$7.8M | -$26.8M | -$14.3M | -$442.5M | -$13.3M | |
| Dividends Paid (Ex Special Dividend) | -$400M | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $315.7M | -- | -- | $245.5M | -- | |
| Long-Term Debt Repaid | -$333M | -- | -- | -$21.7M | -$25.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$116K | |
| Other Financing Activities | $23.7M | -$7.5M | -$2.1M | -$9.8M | -$483K | |
| Cash From Financing | -$72.2M | -$7.5M | -$2.1M | $213.9M | -$25.9M | |
| Beginning Cash (CF) | $208.4M | $255.7M | $303.3M | $378.4M | $199M | |
| Foreign Exchange Rate Adjustment | $870K | -$3.3M | $3.4M | $1.3M | -$2.7M | |
| Additions / Reductions | -$45M | $14.4M | $37.4M | -$156M | -$47.4M | |
| Ending Cash (CF) | $164.2M | $266.7M | $344.1M | $223.7M | $149M | |
| Levered Free Cash Flow | $27.1M | $26.7M | $39.5M | $38.2M | -$21.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $22.7M | $102.6M | $151.1M | $222M | -$65.1M | |
| Depreciation & Amoritzation | $52.7M | $48.6M | $48.7M | $63.7M | $70.4M | |
| Stock-Based Compensation | $47.3M | $21.6M | $66.1M | $43.4M | $41.9M | |
| Change in Accounts Receivable | -$5.3M | -$9.6M | -$18.8M | -$8.9M | $27.9M | |
| Change in Inventories | $1.8M | $9.8M | -$46.9M | -$55.9M | -$34M | |
| Cash From Operations | $96.2M | $175.6M | $183.2M | $216.5M | $54.3M | |
| Capital Expenditures | $36.5M | $70.6M | $63.7M | $140.7M | $48.8M | |
| Cash Acquisitions | -$24.8M | -$15.6M | -$21.7M | -$408.3M | -- | |
| Cash From Investing | -$61M | -$68M | -$85.4M | -$532.8M | -$48.5M | |
| Dividends Paid (Ex Special Dividend) | -$400M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$25.7M | -$76.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$3.9M | -$28M | -$11M | |
| Cash From Financing | -$19.7M | -$6.2M | -$15.8M | $194.8M | -$78.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $15.5M | $101.4M | $82M | -$121.5M | -$72.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $59.7M | $105M | $119.5M | $75.8M | $5.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.4M | $93.9M | $125.5M | $160M | -$58M | |
| Depreciation & Amoritzation | $36.2M | $36.5M | $36.7M | $49.5M | $48.6M | |
| Stock-Based Compensation | $46.9M | $18.6M | $51.2M | $32.8M | $32.3M | |
| Change in Accounts Receivable | -$5.9M | -$6.1M | -$3.9M | -$2.6M | $34.4M | |
| Change in Inventories | $1.1M | $3.3M | -$39.1M | -$19.9M | -$38.1M | |
| Cash From Operations | $63.5M | $118.6M | $145.7M | $169M | $41.6M | |
| Capital Expenditures | $25.9M | $55.8M | $49.6M | $110.5M | $34.6M | |
| Cash Acquisitions | -$24.8M | -$12.5M | -$19.7M | -$408.1M | -- | |
| Cash From Investing | -$50.4M | -$50.1M | -$69.3M | -$502.4M | -$34.2M | |
| Dividends Paid (Ex Special Dividend) | -$400M | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $315.7M | -- | -- | $245.5M | $193.5M | |
| Long-Term Debt Repaid | -$333M | -- | -$7.5M | -$25.7M | -$75.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$853.9M | |
| Other Financing Activities | $23.7M | -$7.5M | -$10.8M | -$23.5M | -$10.9M | |
| Cash From Financing | -$72.2M | -$6.2M | -$16.7M | $198.1M | -$79.2M | |
| Beginning Cash (CF) | $648.2M | $689.2M | $889.4M | $1.1B | $605.4M | |
| Foreign Exchange Rate Adjustment | $3.4M | $604K | -$5.3M | $375K | -$1.3M | |
| Additions / Reductions | -$59.1M | $62.2M | $59.7M | -$135.3M | -$71.9M | |
| Ending Cash (CF) | $592.5M | $752M | $943.7M | $964.5M | $532.2M | |
| Levered Free Cash Flow | $37.7M | $62.8M | $96.1M | $58.5M | $7M | |
Get ALGM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALGM
Sector
P/E ratio
64.55x
23.04x
PEG ratio
0.21x
0.02x
P/B ratio
5.24x
2.22x
Price / LTM sales
6.54x
1.60x
Growth Metrics
ALGM
Sector
Revenue growth
-30.24%
5.29%
Earnings growth
-48.49%
12.31%
Revenue (5-year growth)
7.7%
6.55%
Earnings forecast
$0.08
$0.14
Profitability
ALGM
Sector
Profitability FY 2023
$574.5M
$94.2M
Return on invested capital
-4.85%
1.26%
Return on assets
-4.37%
0.26%
Return on equity
-6.22%
2.38%
Earnings Date
Last Earnings Date
Jan
30
Next Earnings Date
May
9
Estimated Next Earnings Date
May
1
Balance Sheet
ALGM
Sector
Total cash
$138.5M
$56.9M
Short term investments
--
$20.9M
Total assets
$1.5B
$265.7M
Long term debt
$376.1M
$7.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
